- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05594277
Frailty and Surgery
March 3, 2024 updated by: Francesca Moretto, Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
The Impact of Hospitalization After Major Surgery on Elderly Frail Patients: a Prospective Observational Study
Frailty has been recently re-defined as a condition that is evident over time through an excess of vulnerability to stressors, with reduced ability to maintain or regain homeostasis after a destabilizing event, and occurrence of disability.
Frailty has been often used to characterize the weakest and most vulnerable subset of older adults, because of age, comorbidities, social and emotional status leading to the lack of functional and psychological reserve and mining the capability to face acute events.
Frail patients are becoming ever more present in Anesthesia and Intensive Care.
In fact, 30 percent of surgery is conducted on patients ≥ 70 years old nowadays.
It has been demonstrated that the impact of surgery and anesthesiologic risk are greater in older frail subjects, and that a low functional status is associated with increased mortality.
Also, post-operative delirium and cognitive disfunction are more often seen in older patients.
For this reason, the worsening of the global performance status, as functional status, mobility, and cognitive status may have a large impact on patient and caregivers' life.
The primary objective is to evaluate the impact at three months after hospitalization following major surgery i.e., urology, general surgery, orthopedics, on the performance status as functional status, mobility, and cognitive status of patients ≥ 70 years old.
Secondary objectives are to evaluate the necessity of domiciliary care assistance and re-hospitalization or rehabilitation center admissions in three months following surgery and to evaluate the impact of the type of anesthesia used in major surgery i.e., general vs regional anesthesia, on patient performance status.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Novara, Italy, 28100
- Aou Maggiore Della Carita
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
66 years and older (Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients affering to Maggiore della Carità University Hospital and Local Health Authority of Novara, Italy, listed for major surgery in general and vascular surgery, urology, orthopedics
Description
Inclusion Criteria:
- ≥ 70 years old
- Listed for major surgery in general and vascular surgery, urology, orthopedics
- Patient General Practitioner listed in the Local Health Authority of Novara
Exclusion Criteria:
- Barthel index at baseline < 16 in the activities of daily living section
- Barthel index at baseline < 11 in the mobility section
- Mini mental state examination at baseline < 11
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
surgical elderly patients
Patients ≥ 70 years old, undergoing a major surgery in general and vascular surgery, urology, orthopedics at Maggiore della Carità University Hospital, Novara, Italy, having a General Practitioner listed in the Local Health Authority of Novara.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Worsening of the performance status as functional status, mobility, and cognitive status after hospitalization for major surgery
Time Frame: Three months
|
Ten-point worsening of Barthel index globally, in the activities of daily living section and in the mobility section, and worsening of the mini mental state examination three months after surgery
|
Three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Necessity of domiciliary care assistance
Time Frame: Three months
|
Necessity of domiciliary care assistance activation following hospital discharge after major surgery
|
Three months
|
|
Re-hospitalization or rehabilitation center admissions
Time Frame: Three months
|
Necessity of re-hospitalization or rehabilitation center admissions in the three months after major surgery
|
Three months
|
|
Impact of the type of anesthesia used in major surgery, general vs regional anesthesia, on patient performance status
Time Frame: Three months
|
Ten-point worsening of Barthel index globally, in the activities of daily living section and in the mobility section, and worsening of the mini mental state examination three months after surgery based on the type of anesthesia used in major surgery
|
Three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Rosanna Vaschetto, Professor, Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2020
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
October 31, 2023
Study Registration Dates
First Submitted
October 21, 2022
First Submitted That Met QC Criteria
October 21, 2022
First Posted (Actual)
October 26, 2022
Study Record Updates
Last Update Posted (Estimated)
March 6, 2024
Last Update Submitted That Met QC Criteria
March 3, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 421/CE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.